No Data
No Data
Zhejiang CONBA PharmaceuticalLtd's (SHSE:600572) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Zhejiang Conba Pharmaceutical 2024 Interim Report Summary
Zhejiang Conba Pharmaceutical 2024 Interim Report Full Text
Zhejiang Conba Pharmaceutical (600572.SH) released its performance for the first half of the year, with a net income of 0.382 billion yuan, a decrease of 25.95%.
Zhejiang Conba Pharmaceutical (600572.SH) released its 2024 interim report, during which the company achieved a revenue of 3...
Are Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHSE:600572) Investors Paying Above The Intrinsic Value?
Zhejiang Conba Pharmaceutical (600572.SH) has appointed Hu Jiqiang as its honorary director.
On August 16th, Gelunhui reported that Zhejiang Conba Pharmaceutical Co., Ltd. (stock code 600572.SH) held the first meeting of the eleventh board of directors on August 16, 2024 and approved the appointment of Mr. Hu Jiqiang as the honorary chairman of the company. As the term of the 10th board of directors has expired, Mr. Hu Jiqiang will no longer serve as the company's director and chairman from the date of the establishment of the 11th board of directors of the company.
No Data
No Data